Uncertainties and data needs in risk assessment of three commercial polybrominated diphenyl ethers: probabilistic exposure analysis and comparison with European Commission results

Abstract

Some environmental monitoring programs have reported increasing levels of certain polybrominated diphenyl ether (PBDE) isomers in aquatic biota and in human breast milk. The commercial PBDE products are known as penta-, octa-, and deca-brominated diphenyl ethers (PeBDE, OBDE and DBDE, respectively). Aside from the current European Commission's risk assessment initiative and efforts underway in Sweden, Canada and elsewhere to evaluate environmental levels, little is understood about sources of exposure and risks to humans. In this study, a multi-pathway human health risk assessment was performed to predict theoretical chronic daily intakes (CDIs) of PeBDE, OBDE, and DBDE by five different age groups: 0–2, 2–6, 6–12, 12–18, and 18–70 years. Sources of exposure included air, drinking water, consumption of fish, vegetables, meat and dairy products, and ingestion of breast milk by infants. In addition to a deterministic analysis, the risk assessment included a probabilistic analysis to derive the probability density functions describing the range of plausible exposures associated with eight different pathways, as well as aggregate lifetime exposures for each age group. The results were compared to CDI point estimates calculated by the European Chemicals Bureau as part of the European Commission's Existing Substances Programme. The major sources of uncertainties are discussed, including environmental sources, levels in different environmental compartments, toxicity, and human exposure. This paper also discusses the limitations in the current state-of-the-science and provides recommendations for improving the scientific relevance and accuracy of future environmental risk assessments of PBDEs.